FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049550052> ?p ?o ?g. }

• W2049550052 endingPage "330" @default.
• W2049550052 startingPage "329" @default.
• W2049550052 abstract "Equine Veterinary JournalVolume 29, Issue 5 p. 329-330 Matrix metalloproteinases as targets for therapy in equine joint diseases A. P. HOLLANDER, A. P. HOLLANDER Department of Human Metabolism and Clinical Biochemistry University of Sheffield, Medical School Beech Hill Road, Sheffield S10 2RX, UK.Search for more papers by this author A. P. HOLLANDER, A. P. HOLLANDER Department of Human Metabolism and Clinical Biochemistry University of Sheffield, Medical School Beech Hill Road, Sheffield S10 2RX, UK.Search for more papers by this author First published: 23 April 2010 https://doi.org/10.1111/j.2042-3306.1997.tb03133.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References Beckett, R.P. (1996) Recent advances in the field of matrix metalloproteinase inhibitors. Exp. Opin. Ther. Patents 6, 1305– 1315. Brown, C.J., Rahman, S., Morton, A.C., Beauchamp, C.L., Bramwell, H. and Buttle, D.J. (1996) Inhibitors of collagenase but not gelatinase reduce cartilage explant proteoglycan breakdown despite only low levels of matrix metalloproteinases activity. J. clin. Path. mol. Path. 49, M331– M339. Buttle, D.J., Bramwell, H. and Hollander, A.P. (1995) Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy. J. clin. Path. mol. Path. 48, M167– M177. Cawston, T.E. (1993) Blocking cartilage destruction with metalloproteinase inhibitors: a valid therapeutic target. Ann. Rheum. Dis. 52, 769– 770. Cawston, T.E., Ellis, A.J., Humm, G., Lean, E., Ward, D. and Curry, V. (1995) Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage culture. Biochm. Biophys. Res. Commun. 215, 377– 385. Chubinskaya, S., Huch, K., Mikecz, K., Cs-Szabo, G., Hasty, K.A., Kuettner, K.E. and Cole, A.A. (1996) Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1β in human cartilage from knee and ankle joints. Lab. Invest. 74, 232– 240. Clegg, P.D., Burke, R.M., Coughlan, A.R., Riggs, C.M. and Carter, S.D. (1997a) Characterisation of equine matrix metalloproteinase 2 and 9 and identification of the cellular sources of these enzymes in joints. Equine vet. J. 29, 335– 342. Clegg, P.D., Coughlan, A.R., Riggs, C.M. and Carter, S.D. (1997b) Matrix metalloproteinases 2 and 9 in equine synovial fluids. Equine vet. J. 29, 343– 348. Clegg, P.D., Coughlan, A.R. and Carter, S.D. (1997) Equine TIMP-1 and TIMP-2: identification, activity and cellular sources. Equine vet. J. In Press. Freije, J.MP., Diez-Itza, I., Balbin, M., Sanchez, L.M., Blasco, R., Tolivia, J. and Lopez-Otin, C. (1994) Molecular cloing and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269, 16766– 16773. Hardingham, T.E. and Fosang, A.J. (1995) The structure of aggrecan and its turnover in cartilage. J. Rheumatol. 22. Suppl. 43, 86– 90. Hollander, A.P., Pidoux, I., Reiner, A., Rorabeck, C., Bourne, R. and Poole, A.R. (1995) Damage to type II collagen in ageing and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J. clin. Invest. 96, 2859– 2869. Hollander, A.P., Heathfield, T.F., Webber, C., Iwata, Y., Bourne, R., Rorabeck, C. and Poole, A.R. (1994) Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J. clin. Invest. 93, 1722– 1732. Kozaci, L.D., Buttle, D.J. and Hollander, A.P. (1997) Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheum. 40, 164– 174. Lark, M., Gordy, J.T., Weidner, JR., Ayala, J., Kimura, J.H., Williams, H.R., Mumford, R.A., Flannery, C.R., Carlson, S.S., Iwata, M. and Sandy, J.D. (1995) Cell-mediated catabolism of aggrecan. J. Biol. Chem. 270, 2550– 2556. Mitchell, P.G., Magna, H.A., Reeves, L.M., Lopresti-Morrow, L.L., Yocum, S.A., Rosner, P.J., Geoghelgan, K. and Hambor, J.E. (1996) Cloning, expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97, 761– 768. Murphy, G. (1995) Matrix metalloproteinases and their inhibitors. Acta Orthop. Scand. 66, Suppl. 266, 55– 60. Murphy, G. and Reynolds, J.J. (1993) Extracellular matrix degradation. In: Connective Tissue and its Heritable Disorders. Molecular, Genetic and Medical Aspects. Eds: P.M. Royce and B. Steinmann. Wiley-Liss Inc., New York . pp 287– 316. Nguyen, Q., Mort, J.S. and Roughley, P.J. (1992) Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. J. clin. Invest. 89, 1189– 1197. Poole, A.R. (1993) Cartilage in health and disease. In: Arthritis and Allied Conditions: A Textbook of Rheumatology. Eds: D.J. McCarty and W.J. Koopman. Lea and Febiger, Philadelphia . pp 279– 333. Rawlings, N.D. and Barrett, A.J. (1995) Evolutionary families of metallopeptidases. Methods Enzymol. 248, 183– 228. Sandy, J.D., Flannery, C.R., Neame, P.J. and Lohmander, L.S. (1992) The structure of aggrecan fragments in human synovial fluid. J. clin. Invest. 89, 1512– 1516. Citing Literature Volume29, Issue5September 1997Pages 329-330 ReferencesRelatedInformation" @default.
• W2049550052 created "2016-06-24" @default.
• W2049550052 creator A5005826314 @default.
• W2049550052 date "1997-09-01" @default.
• W2049550052 modified "2023-09-24" @default.
• W2049550052 title "Matrix metalloproteinases as targets for therapy in equine joint diseases" @default.
• W2049550052 cites W1488354887 @default.
• W2049550052 cites W1940380821 @default.
• W2049550052 cites W1971481363 @default.
• W2049550052 cites W1978568384 @default.
• W2049550052 cites W2003867975 @default.
• W2049550052 cites W2004488501 @default.
• W2049550052 cites W2022749981 @default.
• W2049550052 cites W2023560282 @default.
• W2049550052 cites W2024460044 @default.
• W2049550052 cites W2039113875 @default.
• W2049550052 cites W2054048187 @default.
• W2049550052 cites W2075236181 @default.
• W2049550052 cites W2084995088 @default.
• W2049550052 cites W2087628254 @default.
• W2049550052 cites W2114769400 @default.
• W2049550052 cites W2138960046 @default.
• W2049550052 doi "https://doi.org/10.1111/j.2042-3306.1997.tb03133.x" @default.
• W2049550052 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9306055" @default.
• W2049550052 hasPublicationYear "1997" @default.
• W2049550052 type Work @default.
• W2049550052 sameAs 2049550052 @default.
• W2049550052 citedByCount "2" @default.
• W2049550052 crossrefType "journal-article" @default.
• W2049550052 hasAuthorship W2049550052A5005826314 @default.
• W2049550052 hasConcept C109523444 @default.
• W2049550052 hasConcept C126322002 @default.
• W2049550052 hasConcept C161191863 @default.
• W2049550052 hasConcept C41008148 @default.
• W2049550052 hasConcept C71924100 @default.
• W2049550052 hasConceptScore W2049550052C109523444 @default.
• W2049550052 hasConceptScore W2049550052C126322002 @default.
• W2049550052 hasConceptScore W2049550052C161191863 @default.
• W2049550052 hasConceptScore W2049550052C41008148 @default.
• W2049550052 hasConceptScore W2049550052C71924100 @default.
• W2049550052 hasIssue "5" @default.
• W2049550052 hasLocation W20495500521 @default.
• W2049550052 hasLocation W20495500522 @default.
• W2049550052 hasOpenAccess W2049550052 @default.
• W2049550052 hasPrimaryLocation W20495500521 @default.
• W2049550052 hasRelatedWork W1506200166 @default.
• W2049550052 hasRelatedWork W1995515455 @default.
• W2049550052 hasRelatedWork W2039318446 @default.
• W2049550052 hasRelatedWork W2048182022 @default.
• W2049550052 hasRelatedWork W2080531066 @default.
• W2049550052 hasRelatedWork W2604872355 @default.
• W2049550052 hasRelatedWork W2748952813 @default.
• W2049550052 hasRelatedWork W2899084033 @default.
• W2049550052 hasRelatedWork W3032375762 @default.
• W2049550052 hasRelatedWork W3108674512 @default.
• W2049550052 hasVolume "29" @default.
• W2049550052 isParatext "false" @default.
• W2049550052 isRetracted "false" @default.
• W2049550052 magId "2049550052" @default.
• W2049550052 workType "article" @default.